- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Complaint about Lantus promotional leavepieces and a mailer. Issues included “24-hour efficacy” wording and comparative hypoglycaemia claims based…
A nurse alleged she was suspended for refusing to share confidential unit/customer data from an infusion service facilitation…
Alcon’s Azarga leavepiece repeatedly used “comfort/comfortable”. Appeal Board allowed the comparative “Significantly more comfortable than Cosopt” claim (with…
PMCPA case summary: Anonymous non-contactable complainant vs PharmaMar (AUTH/2979/9/17). Case details, clauses, outcome and sanctions were not stated…
A two-page Amias ad compared ARBs in heart failure and marked losartan as a black triangle drug. PMCPA…
UCB voluntarily admitted a paid advertorial in a Parkinson’s Disease supplement distributed with The Times that named Keppra…
A Qutenza journal insert styled as a ‘consensus statement’ and ‘adapted from NICE’ was ruled misleading: funding/organisation by…
Ex-employee alleged archived investor presentations made false/imbalanced claims about Seroquel and weight gain. Panel and Appeal Board ruled…
Pierre Fabre admitted multiple ABPI Code breaches after using and emailing uncertified cycle-meeting materials for Toviaz, including misleading…
A member of the public alleged MSD failed to disclose clinical trial results on time for Brinavess, Sycrest…
One real case. One key lesson. Every week — free.